In the cardiovascular system, excessively high O‐GlcNAcylation can promote HF by activating the mTOR pathway or induce ventricular cardiomyocyte hypertrophy through PKA pathway activation, significantly exacerbating cardiovascular pathology. Here, MTOR is linked to cardiac hypertrophy.